| 摘要 |
<p>This description discloses processes for making 5- or 6-alkylated pyrimidine nucleoside analogues and 2- or 8-alkylated purine nucleoside analogues by contacting the corresponding halopyrimidine or halopurine nucleoside with a functionalized alkene in the presence of a palladium (0) catalyst.</p> |
